Basic Research

From Wikipedia, the free encyclopedia

Basic Research is an herbal supplement and cosmetics manufacturer based in Salt Lake City, Utah that distributes products through a large number of subsidiaries. In addition, their products are sold domestically and internationally through a number of high-end retailers. Dennis Gay is the president and chief executive officer of Basic Research.[1]

Subsidiaries of the company include "Basic Research" which markets the sports nutrition products Endothil-CR and Oxydrene. "Zoller Labratories" markets the Zantrex-3 energy/weight-loss product. "Dynakor Pharmacal" claims to be a Russian company that manufactures the weight-loss products Formula9 and AKAVAR 20/50. These subsidiaries are all housed in the same complex in Salt Lake City and are simply used as a means to market different products to different demographics.[citation needed]

In addition, Basic Research has another subsidiary called "Generix Labs". This company sells the product Striadril, which is billed as a generic version of the Strivectin-SD product at a fraction of the cost. Many customers are not aware that Striadril is the exact same product as Strivectin-SD, manufactured by the exact same company, just with a different package and price point to attract a lower-end consumer.[citation needed]

Several products manufactured by Basic Research, such as Relacore and Strivectin-SD have come under scrutiny by the FDA for making claims that cannot be substantiated or that would place the product under FDA regulation as a controlled substance.[2] [3] [4]

[edit] References

  1. ^ FTC targets Utah weight-loss products, Deseret News (Salt Lake City), Jun 17, 2004 by Jenifer K. Nii
  2. ^ "Warning Letters Address Claims Made forTopical Skincare Preparations" (March 2007): C03. 
  3. ^ "Casewatch FDA Letters to Basic Research" (January 2005): C03. 
  4. ^ "Official Akavar Site" .